The Scientific and Research Team at Achillestx is responsible for developing and optimizing personalized T cell therapies targeting neoantigens. This multidisciplinary team conducts cutting-edge immunological research, ensures quality control in lab operations, utilizes bioinformatics for data analysis, and implements advanced AI techniques to innovate and enhance therapeutic approaches. They collaborate extensively to translate scientific discoveries into clinical applications, aiming to improve patient outcomes in oncology settings.
View all